Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/39013
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorRamírez Pineda, José Robinson-
dc.contributor.authorBerberich, Christof Ernest-
dc.contributor.authorJaramillo Ramírez, Andrés-
dc.contributor.authorAlonso, Carlos-
dc.contributor.authorVélez Bernal, Iván Darío-
dc.date.accessioned2024-04-12T18:17:31Z-
dc.date.available2024-04-12T18:17:31Z-
dc.date.issued1998-
dc.identifier.citationRamírez JR, Berberich C, Jaramillo A, Alonso C, Vélez ID. Molecular and Antigenic Characterization of the Leishmania (Viannia) panamensis Kinetoplastid Membrane Protein-11. Mem Inst Oswaldo Cruz [Internet]. 1998Mar;93(2):247–54. Available from: https://doi.org/10.1590/S0074-02761998000200022spa
dc.identifier.issn0074-0276-
dc.identifier.urihttps://hdl.handle.net/10495/39013-
dc.description.abstractABSTRACT: The kinetoplastid membrane protein 11 (KMP-11) has been recently described in Leishmania (Leishmania) donovani as a major component of the promastigote membrane. Two oligonucleotide primers were synthesized to PCR-amplify the entire coding region of New World Leishmania species. The Leishmania (Viannia) panamensis amplification product was cloned, sequenced and the putative amino acid sequence determined. A remarkably high degree of sequence homology was observed with the corresponding molecule of L. (L) donovani and L. (L) infantum (97% and 96%, respectively). Southern blot analysis showed that the KMP-11 locus is conformed by three copies of the gene. The L. (V) panamensis ORF was subsequently cloned in a high expression vector and the recombinant protein was induced and purified from Escherichia coli cultures. Immunoblot analysis showed that 80%, 77% and 100% sera from cutaneous, mucocutaneous and visceral leishmaniasis patients, respectively, recognized the recombinant KMP-11 protein. In a similar assay, 86% of asymptomatic Leishmania-infected individuals showed IgG antibodies against the rKMP-11. We propose that KMP-11 could be used as a serologic marker for infection and disease caused by Leishmania in America.spa
dc.format.extent8 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherInstituto Oswaldo Cruzspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/co/*
dc.titleMolecular and Antigenic Characterization of the Leishmania (Viannia) panamensis Kinetoplastid Membrane Protein-11spa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupPrograma de Estudio y Control de Enfermedades Tropicales (PECET)spa
dc.identifier.doi10.1590/S0074-02761998000200022-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1678-8060-
oaire.citationtitleMemórias do Instituto Oswaldo Cruzspa
oaire.citationstartpage247spa
oaire.citationendpage253spa
oaire.citationvolume93spa
oaire.citationissue2spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
oaire.fundernameUniversidad de Antioquia. Vicerrectoría de investigación. Comité para el Desarrollo de la Investigación - CODIspa
oaire.fundernameColombia. Ministerio de Ciencia, Tecnología e Innovación - Mincienciasspa
dc.publisher.placeRío de Janeiro, Brasilspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsAnticuerpos Monoclonales-
dc.subject.decsAntibodies, Monoclonal-
dc.subject.decsExpresión Génica-
dc.subject.decsGene Expression-
dc.subject.decsLeishmania guyanensis-
dc.subject.decsLeishmaniasis-
dc.subject.decsProteínas de la Membrana - química-
dc.subject.decsMembrane Proteins - chemistry-
dc.subject.decsProteínas Recombinantes - aislamiento y purificación-
dc.subject.decsRecombinant Proteins - isolation and purification-
dc.subject.decsAnálisis de Secuencia de ADN-
dc.subject.decsSequence Analysis, DNA-
dc.description.researchgroupidCOL0015099spa
oaire.awardnumberCIM9605 and CIM9750spa
oaire.awardnumber1115-14436-95spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D000911-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D015870-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D018334-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D007896-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D008565-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D011994-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D017422-
dc.relation.ispartofjournalabbrevMem. Inst. Oswaldo Cruz.spa
oaire.funderidentifier.rorRoR:03bp5hc83-
oaire.funderidentifier.rorRoR:03fd5ne08-
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
VelezIvan_1998_Molecular_Antigenic_Viannia.pdfArtículo de investigación280.85 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons